Thrivent Financial for Lutherans’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,159
| Closed | -$236K | – | 2529 |
|
|
2020
Q3 | $236K | Sell |
25,159
-3,528
| -12% | -$33.1K | ﹤0.01% | 2254 |
|
|
2020
Q2 | $219K | Buy |
28,687
+262
| +0.9% | +$2K | ﹤0.01% | 2193 |
|
|
2020
Q1 | $176K | Buy |
28,425
+1,419
| +5% | +$8.79K | ﹤0.01% | 2142 |
|
|
2019
Q4 | $329K | Buy |
27,006
+9
| +0% | +$110 | ﹤0.01% | 2045 |
|
|
2019
Q3 | $312K | Buy |
26,997
+626
| +2% | +$7.24K | ﹤0.01% | 2021 |
|
|
2019
Q2 | $263K | Sell |
26,371
-15
| -0.1% | -$150 | ﹤0.01% | 2066 |
|
|
2019
Q1 | $340K | Buy |
26,386
+1,750
| +7% | +$22.6K | ﹤0.01% | 1963 |
|
|
2018
Q4 | $374K | Buy |
24,636
+541
| +2% | +$8.21K | ﹤0.01% | 1722 |
|
|
2018
Q3 | $482K | Buy |
24,095
+547
| +2% | +$10.9K | ﹤0.01% | 1699 |
|
|
2018
Q2 | $459K | Buy |
23,548
+606
| +3% | +$11.8K | ﹤0.01% | 1726 |
|
|
2018
Q1 | $462K | Buy |
22,942
+1,010
| +5% | +$20.3K | ﹤0.01% | 1681 |
|
|
2017
Q4 | $291K | Buy |
21,932
+432
| +2% | +$5.73K | ﹤0.01% | 1898 |
|
|
2017
Q3 | $397K | Buy |
21,500
+440
| +2% | +$8.13K | ﹤0.01% | 1674 |
|
|
2017
Q2 | $388K | Sell |
21,060
-100,770
| -83% | -$1.86M | ﹤0.01% | 1649 |
|
|
2017
Q1 | $2.75M | Buy |
121,830
+103,450
| +563% | +$2.33M | 0.01% | 742 |
|
|
2016
Q4 | $640K | Buy |
18,380
+1,000
| +6% | +$34.8K | ﹤0.01% | 1387 |
|
|
2016
Q3 | $426K | Buy |
17,380
+440
| +3% | +$10.8K | ﹤0.01% | 1536 |
|
|
2016
Q2 | $405K | Buy |
16,940
+1,480
| +10% | +$35.4K | ﹤0.01% | 1520 |
|
|
2016
Q1 | $362K | Buy |
+15,460
| New | +$362K | ﹤0.01% | 1526 |
|